多态性,蛋白质和表型.

M Steel¹

¹MRC Human Genetics Unit, Edinburgh, UK.

Lancet (London, England)

|January 23, 1993

概括

No abstract available in PubMed .

相关概念视频

您也可能阅读

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Comparison of thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant eligible.

Annals of hematology·2020

Same author

Minimum triplet covers of binary phylogenetic X-trees.

Journal of mathematical biology·2017

Same author

FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases.

Acta oncologica (Stockholm, Sweden)·2017

Same author

Dysphoria is a risk factor for depression in medically ill older people.

International journal of geriatric psychiatry·2016

Same author

Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.

British journal of cancer·2014

Same author

Long wavelength anti-resonant guidance in high index inclusion microstructured fibers.

Optics express·2009

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

查看所有相关文章

相关实验视频

多态性,蛋白质和表型.

相关概念视频

Comparison of thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant eligible.

Minimum triplet covers of binary phylogenetic X-trees.

FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases.

Dysphoria is a risk factor for depression in medically ill older people.

Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.

Long wavelength anti-resonant guidance in high index inclusion microstructured fibers.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

多态性,蛋白质和表型.

相关概念视频

Comparison of thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant eligible.

Minimum triplet covers of binary phylogenetic X-trees.

FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases.

Dysphoria is a risk factor for depression in medically ill older people.

Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.

Long wavelength anti-resonant guidance in high index inclusion microstructured fibers.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.